Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
52
ESGR Quote, Financials, Valuation and Earnings
Last price:
$334.97
Seasonality move
:
5.49%
Day range:
$334.65 - $335.40
52-week range:
$291.90 - $348.48
Dividend yield:
0%
P/E ratio:
10.67x
P/S ratio:
4.43x
P/B ratio:
0.88x
Volume:
97.6K
Avg. volume:
88.7K
1-year change:
6.38%
Market cap:
$5B
Revenue:
$1.2B
EPS (TTM):
$31.39
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $696M | -$1.1B | $1.4B | $1.2B | |
| Revenue Growth (YoY) | 20.12% | -73.45% | -- | -- | -13.93% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $502M | $367M | $331M | $369M | $391M | |
| Other Inc / (Exp) | $140M | $42M | $39M | $288M | $67M | |
| Operating Expenses | $505M | $440M | $333M | $357M | $288M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $59M | $69M | $95M | $90M | $89M | |
| EBT. Incl. Unusual Items | $1.5B | $487M | -$883M | $955M | $661M | |
| Earnings of Discontinued Ops. | $16M | -- | -- | -- | -- | |
| Income Tax Expense | $24M | $27M | -$12M | -$250M | $62M | |
| Net Income to Company | $1.7B | $553M | -$945M | $1.2B | $581M | |
| Minority Interest in Earnings | $28M | -$15M | $75M | -$100M | -$5M | |
| Net Income to Common Excl Extra Items | $1.8B | $538M | -$870M | $1.1B | $576M | |
| Basic EPS (Cont. Ops) | $79.95 | $25.33 | -$52.65 | $69.22 | $36.83 | |
| Diluted EPS (Cont. Ops) | $78.97 | $24.94 | -$52.65 | $68.47 | $35.90 | |
| Weighted Average Basic Share | $21.6M | $19.8M | $17.2M | $15.6M | $14.7M | |
| Weighted Average Diluted Share | $21.8M | $20.1M | $17.3M | $15.8M | $15M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.6B | $555M | -$790M | $1B | $748M | |
| Revenue (Reported) | $2.6B | $696M | -$1.1B | $1.4B | $1.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.6B | $555M | -$790M | $1B | $748M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $137M | -$301M | $624M | $254M | $180M | |
| Revenue Growth (YoY) | -- | -- | -- | -59.3% | -29.13% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $83M | $85M | $89M | $87M | $91M | |
| Other Inc / (Exp) | $10M | $14M | $280M | $3M | $3M | |
| Operating Expenses | $98M | $85M | $89M | $84M | $87M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $16M | $25M | $23M | $22M | $23M | |
| EBT. Incl. Unusual Items | $79M | -$278M | $507M | $138M | $55M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$6M | -- | -$1M | $5M | -- | |
| Net Income to Company | $203M | -$247M | $519M | $128M | $59M | |
| Minority Interest in Earnings | -$11M | -$11M | -$86M | -- | -- | |
| Net Income to Common Excl Extra Items | $192M | -$258M | $433M | $128M | $59M | |
| Basic EPS (Cont. Ops) | $8.50 | -$15.19 | $24.97 | $8.13 | $3.36 | |
| Diluted EPS (Cont. Ops) | $8.38 | -$15.19 | $24.79 | $8.02 | $3.32 | |
| Weighted Average Basic Share | $21.6M | $17.6M | $17M | $14.6M | $14.9M | |
| Weighted Average Diluted Share | $21.9M | $17.8M | $17.1M | $14.8M | $15.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $95M | -$253M | $530M | $160M | $78M | |
| Revenue (Reported) | $137M | -$301M | $624M | $254M | $180M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $95M | -$253M | $530M | $160M | $78M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $265M | -$161M | $1B | $1.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $486.6M | $369M | $335M | $367M | $395M | |
| Other Inc / (Exp) | $129.6M | $46M | $305M | $11M | $70M | |
| Operating Expenses | $504.6M | $427M | $335M | $352M | $288M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $61.6M | $78M | $93M | $89M | $90M | |
| EBT. Incl. Unusual Items | $2.1B | $130M | -$98M | $586M | $578M | |
| Earnings of Discontinued Ops. | $18.1M | -- | -- | -- | -- | |
| Income Tax Expense | $23.3M | $33M | -$13M | -$244M | $57M | |
| Net Income to Company | $2.5B | $103M | -$179M | $827M | $512M | |
| Minority Interest in Earnings | -$15.7M | -$15M | -- | -$14M | -$5M | |
| Net Income to Common Excl Extra Items | $2.5B | $88M | -$179M | $813M | $507M | |
| Basic EPS (Cont. Ops) | $112.40 | -$0.88 | -$12.66 | $52.09 | $32.06 | |
| Diluted EPS (Cont. Ops) | $111.10 | -$1.18 | -$12.84 | $51.50 | $31.39 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.2B | $207M | -$7M | $673M | $666M | |
| Revenue (Reported) | $3.1B | $265M | -$161M | $1B | $1.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.2B | $207M | -$7M | $673M | $666M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $137M | -$301M | $624M | $254M | $180M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $83M | $85M | $89M | $87M | $91M | |
| Other Inc / (Exp) | $10M | $14M | $280M | $3M | $3M | |
| Operating Expenses | $98M | $85M | $89M | $84M | $87M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $16M | $25M | $23M | $22M | $23M | |
| EBT. Incl. Unusual Items | $79M | -$278M | $507M | $138M | $55M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$6M | -- | -$1M | $5M | -- | |
| Net Income to Company | $203M | -$247M | $519M | $128M | $59M | |
| Minority Interest in Earnings | -$11M | -$11M | -$86M | -- | -- | |
| Net Income to Common Excl Extra Items | $192M | -$258M | $433M | $128M | $59M | |
| Basic EPS (Cont. Ops) | $8.50 | -$15.19 | $24.97 | $8.13 | $3.36 | |
| Diluted EPS (Cont. Ops) | $8.38 | -$15.19 | $24.79 | $8.02 | $3.32 | |
| Weighted Average Basic Share | $21.6M | $17.6M | $17M | $14.6M | $14.9M | |
| Weighted Average Diluted Share | $21.9M | $17.8M | $17.1M | $14.8M | $15.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $95M | -$253M | $530M | $160M | $78M | |
| Revenue (Reported) | $137M | -$301M | $624M | $254M | $180M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $95M | -$253M | $530M | $160M | $78M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $901M | $1.6B | $822M | $564M | $1.1B | |
| Short Term Investments | $3.7B | $5.7B | $5.3B | $5.3B | $4.9B | |
| Accounts Receivable, Net | $2.3B | $1.7B | $1.3B | $1.1B | $884M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $6.9B | $9.1B | $7.5B | $7.6B | $7.4B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $9.9B | $11.9B | $11.3B | $12.7B | $11.9B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $21.6B | $24.7B | $22.2B | $20.9B | $20.4B | |
| Accounts Payable | $475M | $254M | $100M | $43M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $660M | $254M | $100M | -- | -- | |
| Long-Term Debt | $1.2B | $1.7B | $1.8B | $1.8B | $1.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $14.6B | $17.9B | $16.8B | $15.3B | $14.3B | |
| Common Stock | $529M | $527M | $526M | $525M | $525M | |
| Other Common Equity Adj | $81M | -$16M | -$302M | -$336M | -$341M | |
| Common Equity | $6.2B | $5.8B | $4.5B | $5B | $5.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $379M | $409M | $354M | $113M | $6M | |
| Total Equity | $7.1B | $6.7B | $5.3B | $5.6B | $6.1B | |
| Total Liabilities and Equity | $21.6B | $24.7B | $22.2B | $20.9B | $20.4B | |
| Cash and Short Terms | $4.6B | $7.3B | $6.1B | $5.9B | $6B | |
| Total Debt | $1.4B | $1.7B | $1.8B | $1.8B | $1.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $562.3M | $763M | $828M | $450M | $1.2B | |
| Short Term Investments | $4.7B | $5.3B | $5.2B | $5.1B | $5.3B | |
| Accounts Receivable, Net | $2.7B | $1.6B | $1.3B | $1.1B | $885M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $8B | $7.7B | $7.4B | $6.7B | $7.8B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $11B | $11.5B | $8.9B | $10.4B | $12B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $22.1B | $23.2B | $20.3B | $20.3B | $20.3B | |
| Accounts Payable | $610.3M | $267M | $74M | $107M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $785.3M | $267M | $74M | $107M | -- | |
| Long-Term Debt | $1.2B | $1.9B | $1.8B | $1.8B | $1.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $15.1B | $17.3B | $15.3B | $14.5B | $14.1B | |
| Common Stock | $529M | $527M | $526M | $525M | $525M | |
| Other Common Equity Adj | -$17.7M | -$257M | -$496M | -$364M | -$275M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $187.5M | $414M | $177M | $114M | $6M | |
| Total Equity | $6.9B | $5.9B | $5.1B | $5.7B | $6.2B | |
| Total Liabilities and Equity | $22.1B | $23.2B | $20.3B | $20.3B | $20.3B | |
| Cash and Short Terms | $5.2B | $6.1B | $6B | $5.5B | $6.5B | |
| Total Debt | $1.4B | $1.9B | $1.8B | $1.8B | $1.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7B | $553M | -$945M | $1.2B | $581M | |
| Depreciation & Amoritzation | $59M | $74M | $47M | $7M | -$11M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $52M | $248M | $375M | $142M | $248M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.8B | $3.8B | $257M | $523M | $483M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$14M | -$420M | -- | $48M | $100M | |
| Cash From Investing | -$2.3B | -$2.6B | -$919M | -$148M | $286M | |
| Dividends Paid (Ex Special Dividend) | -$36M | -$36M | -$36M | -$36M | -$36M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $859M | $816M | $494M | -- | -- | |
| Long-Term Debt Repaid | -$679M | -$574M | -$356M | -- | -- | |
| Repurchase of Common Stock | -$26M | -$942M | -$163M | -$531M | -- | |
| Other Financing Activities | -- | -$1M | -$55M | -$294M | -$6M | |
| Cash From Financing | $118M | -$737M | -$116M | -$861M | -$42M | |
| Beginning Cash (CF) | $971M | $1.4B | $2.1B | $1.3B | $830M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $547M | $491M | -$778M | -$486M | $727M | |
| Ending Cash (CF) | $1.4B | $2.1B | $1.3B | $830M | $1.6B | |
| Levered Free Cash Flow | $2.8B | $3.8B | $257M | $523M | $483M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $203M | -$247M | $519M | $128M | $59M | |
| Depreciation & Amoritzation | $18M | $17M | $2M | -$5M | -$2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $38M | $143M | -$64M | $57M | -$4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $808M | -$643M | $70M | -$168M | $143M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$232M | -- | -- | -- | -- | |
| Cash From Investing | -$1.4B | -$481M | $94M | $102M | -$321M | |
| Dividends Paid (Ex Special Dividend) | -$9M | -$9M | -$9M | -$9M | -$9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $20M | $493M | -- | -- | $345M | |
| Long-Term Debt Repaid | -$30M | -$280M | -- | -- | -$233M | |
| Repurchase of Common Stock | -$4M | -$42M | -$340M | -- | -- | |
| Other Financing Activities | -- | -- | -- | $1M | -- | |
| Cash From Financing | -$23M | $162M | -$349M | -$8M | $103M | |
| Beginning Cash (CF) | $1.4B | $2.1B | $1.3B | $830M | $1.6B | |
| Foreign Exchange Rate Adjustment | $1M | $5M | -$2M | $4M | $2M | |
| Additions / Reductions | -$602M | -$962M | -$185M | -$74M | -$75M | |
| Ending Cash (CF) | $996M | $1.1B | $1.1B | $760M | $1.5B | |
| Levered Free Cash Flow | $808M | -$643M | $70M | -$168M | $143M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.5B | $103M | -$179M | $827M | $512M | |
| Depreciation & Amoritzation | $66.4M | $73M | $32M | -- | -$8M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $73.3M | $353M | $168M | $263M | $187M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.5B | $2.4B | $970M | $285M | $794M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$246M | -$188M | -- | $48M | $100M | |
| Cash From Investing | -$3.4B | -$1.7B | -$344M | -$140M | -$137M | |
| Dividends Paid (Ex Special Dividend) | -$36.1M | -$36M | -$36M | -$36M | -$36M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $515M | $1.3B | -- | -- | -- | |
| Long-Term Debt Repaid | -$695M | -$824M | -- | -- | -- | |
| Repurchase of Common Stock | -$17.5M | -$980M | -$461M | -$191M | -- | |
| Other Financing Activities | -- | -- | -- | -$293M | -- | |
| Cash From Financing | -$233.5M | -$552M | -$627M | -$520M | $69M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$153.5M | $131M | -$1M | -$375M | $726M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.5B | $2.4B | $970M | $285M | $794M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $203M | -$247M | $519M | $128M | $59M | |
| Depreciation & Amoritzation | $18M | $17M | $2M | -$5M | -$2M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $38M | $143M | -$64M | $57M | -$4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $808M | -$643M | $70M | -$168M | $143M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$232M | -- | -- | -- | -- | |
| Cash From Investing | -$1.4B | -$481M | $94M | $102M | -$321M | |
| Dividends Paid (Ex Special Dividend) | -$9M | -$9M | -$9M | -$9M | -$9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $20M | $493M | -- | -- | $345M | |
| Long-Term Debt Repaid | -$30M | -$280M | -- | -- | -$233M | |
| Repurchase of Common Stock | -$4M | -$42M | -$340M | -- | -- | |
| Other Financing Activities | -- | -- | -- | $1M | -- | |
| Cash From Financing | -$23M | $162M | -$349M | -$8M | $103M | |
| Beginning Cash (CF) | $1.4B | $2.1B | $1.3B | $830M | $1.6B | |
| Foreign Exchange Rate Adjustment | $1M | $5M | -$2M | $4M | $2M | |
| Additions / Reductions | -$602M | -$962M | -$185M | -$74M | -$75M | |
| Ending Cash (CF) | $996M | $1.1B | $1.1B | $760M | $1.5B | |
| Levered Free Cash Flow | $808M | -$643M | $70M | -$168M | $143M | |
Get ESGR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ESGR
Sector
P/E ratio
10.67x
11.67x
PEG ratio
0.09x
0.39x
P/B ratio
0.88x
1.05x
Price / LTM sales
4.43x
2.53x
Growth Metrics
ESGR
Sector
Revenue growth
-29.13%
5.04%
Earnings growth
-58.6%
2.87%
Revenue (5-year growth)
-11.2%
5.18%
Earnings forecast
--
$0.56
Profitability
ESGR
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
6.45%
5.3%
Return on assets
2.51%
0.97%
Return on equity
8.44%
9.25%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Jul
31
Balance Sheet
ESGR
Sector
Total cash
$6.5B
$470.2M
Short term investments
$4.9B
$233.7M
Total assets
$20.4B
$4B
Long term debt
$1.9B
$296.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
